Tympanogen

Executive Summary

Tympanogen is a private medical device company headquartered in Richmond, Virginia, dedicated to advancing ear, nose, and throat (ENT) surgical solutions. The company’s flagship product, Perf-Fix™, is a novel gel patch system designed for the nonsurgical repair of tympanic membrane (eardrum) perforations. This minimally invasive approach aims to simplify the treatment of chronic otitis media and traumatic perforations, addressing a significant unmet need in outpatient ENT care. By enabling in-office closure without general anesthesia or complex microsurgery, Perf-Fix has the potential to reduce procedure time, lower costs, and improve patient outcomes. The device targets a large addressable market, with millions of eardrum perforations occurring annually worldwide.

Upcoming Catalysts (preview)

• Q4 2026Completion of pivotal clinical trial for Perf-Fix60% success
• Q1 2027FDA 510(k) clearance or de novo request submission50% success
• H2 2026Strategic partnership or licensing agreement for commercialization40% success